China Just Ended Zero-COVID. What the Abrupt December 7 Policy Reversal Means for Chemical Factory Restarts and Q1 2023 Order Planning

On 7 December, the National Health Commission pulled the pin on zero-COVID with ten measures that read like somebody had deleted three years of policy in a single afternoon. No more mass PCR to board a train. Home isolation instead of Fangcang camps. Cross-province travel without the green code gauntlet. For anyone importing chemicals out of China, this was meant to be the moment things opened up. Within eight days it became the biggest factory staffing crisis since Wuhan.

The rub is simple. Testing stopped, infections stopped being counted, and the virus tore through workforces that had been shielded for two and a half years. By 13 December, managers at three separate specialty chemical plants in the Nantong and Zibo clusters were quietly telling their Australian and US buyers the same thing: 40 to 60 per cent of the line was off sick, some shifts running with a skeleton four-person crew covering what should be twelve. If you’re holding Q1 2023 orders against a Chinese origin and you’ve priced them on anything like normal lead times, you’re looking at a six to ten week slip on a base case and a force majeure conversation on a worst case.

The paradox is the part nobody at head office wants to hear. Reopening doesn’t mean recovery. It means a production collapse first, then a recovery that starts somewhere in late February and probably doesn’t normalise until after the Dragon Boat holiday in June. You need to plan orders around that curve, not around the PR line coming out of Beijing.

The Ten Measures and Why Factories Broke Before They Recovered

The State Council’s 7 December notice wasn’t a tweak, it was a demolition. Quarantine for close contacts went from central facility to home. Asymptomatic and mild cases could isolate at home. Nucleic acid testing was scrapped for pharmacies, public transport, offices, and cross-province travel. Lockdowns of “high risk areas” could no longer extend to entire districts, residential compounds, or cities. Schools without outbreaks had to stay open. Migrant workers could move freely again.

Read that list from the perspective of a chemical plant manager in Taixing, Jiangsu. You’ve got 800 workers in a park, most of them dormitory-housed, many of them migrants from Anhui, Henan, and Jiangxi who have been stuck on site rotating tests for eighteen months. On 7 December, they can leave. On 8 December, they’re sick. On 12 December, their replacements are sick. Omicron BA.5.2 and BF.7 have an R0 north of 15 in an immunologically naive population, and the Chinese population is naive because zero-COVID did exactly what it said on the tin until the moment it didn’t.

Caixin’s on-the-ground reporting out of Shijiazhuang, the test case city that was “opened” three weeks earlier, gave us the shape of the curve. Fever clinics at 6x to 10x baseline volume. Paracetamol and ibuprofen off shelves by day four. Beijing subway ridership down 60 per cent not because of policy but because nobody was well enough to commute. That’s what was about to hit every industrial cluster in eastern China over the next six weeks.

For chemical production specifically, three things compound the pain. Continuous-process plants (think MDI at Wanhua, ethylene oxide derivatives across Sinopec Zhenhai, acrylates at the Shandong clusters) can’t just be run on a skeleton crew. Safety requires minimum staffing for control rooms, for emergency response, for loading and unloading hazardous materials. Drop below those thresholds and the plant either runs at reduced rate or shuts the unit. Second, QC labs and certification paperwork (the SGS and Bureau Veritas guys, the in-house analytical teams) got hit just as hard, which means finished product can physically exist but cannot ship because nobody has signed the CoA. Third, trucking inside China, already stressed by the patchwork of local COVID rules through November, fell off a cliff as drivers went home and stayed home.

The Factory-Level Damage Assessment You Actually Need

Here’s what the operational reality looks like across the major chemical-producing provinces in the two weeks to 15 December. These numbers come from direct conversations with suppliers and freight forwarders, not official statistics, because official statistics stopped being reported on 14 December.

Guangdong is furthest along because it opened first, effectively in early November when Guangzhou’s Haizhu district couldn’t hold the line. Jiangsu and Shandong are the hardest hit because they’re furthest behind on the infection curve and they carry more of the continuous-process heavy load that breaks first when staffing goes. The recovery windows in that last column are not “back to normal.” They’re “back to the operating rate you saw in October 2022.” Normal normal is a Q2 story.

Overlay Chinese New Year on top of this. The Spring Festival in 2023 falls on 22 January. Even in a normal year, factories wind down from roughly 15 January and don’t fully restart until 10 to 15 February. This year, most workers will travel home for the first time in three years. They will infect the rest of the country on the way. They will come back sick, late, or in some cases not at all, because migrant worker retention after an extended break has been trending down since 2020. Factor in another 10 to 15 per cent labour friction on the restart.

Q1 2023 Landed Cost: The Arithmetic on a Phthalate Plasticiser Order

Let’s make this concrete. Say you’re a Sydney importer bringing in 80 tonnes (four 20-foot containers at roughly 20 MT each, allowing for flexitank or drummed) of a mid-market ortho-phthalate plasticiser, HS 2917.34, CAS 117-81-7 equivalent family, ex-Ningbo to Port Botany. Pre-reopening, your FOB Ningbo was sitting around USD 1,240 per MT on a December spot. Ocean freight had crashed from the 2021 peak to roughly USD 1,800 per FEU on the China to Australia east coast lane. Here’s the pre-disruption stack and the Q1 2023 stressed stack side by side.

That’s a USD 14,795 hit on a single 80-tonne order, or 12.6 per cent on landed cost, and it does not include the cost of being out of stock if the vessel misses its window. The demurrage and detention line isn’t padding. With factory documentation delays pushing release of the bill of lading by five to twelve days against normal, and with Sydney stevedores still charging detention after seven free days on the container, you will wear days at USD 180 to USD 300 per day per box. Build it in or wear it.

The line most people miss is inland China from plant to container yard. A USD 16 per MT uplift looks trivial until you realise it’s almost 75 per cent on that single cost component, driven by driver shortages, quarantine checkpoints that were meant to be gone but aren’t fully gone, and fuel surcharges that reset on 5 December.

Why “Reopening” Makes February Worse Than December

There’s a counterintuitive bit here that needs spelling out. December damage, bad as it is, is front-loaded in the biggest provinces. January gets worse, not better, for three reasons.

First, the wave moves inland. The coastal provinces where most export-grade chemical production sits caught it first because they’re denser, more mobile, and better connected. Inland provinces (Henan, Hubei, Sichuan, Anhui) are one to three weeks behind. That’s where a large share of your raw material and intermediate supply comes from, even if the final synthesis happens on the coast. A coastal plant that’s recovering on the staffing side in mid-January can still be starved of feedstock because its Henan supplier is in peak infection.

Second, Chinese New Year travel multiplies exposure and drops labour availability to zero for a fortnight minimum. Ministry of Transport forecast 2.09 billion trips for Spring Festival travel 2023, up 99.5 per cent year on year. That isn’t a typo. Migration on that scale, into households that have mostly never been infected, is a second wave detonator.

Third, port operations and customs clearance (GACC) lag production. Even when plants come back online in late February, the backlog of finished product, documentation, and container bookings has to clear. We saw exactly this pattern after Shanghai’s April-May 2022 lockdown, where physical production recovered in June but landed shipments into Sydney didn’t normalise until August. Expect the same geometry on this one.

Six Things to Do Before 31 December 2022

You can’t fix the virus. You can fix your order book.

1. Pull forward every Q1 2023 order you can finance. If your supplier has any stock in Ningbo CFS or Shanghai Waigaoqiao, book it now on the first available sailing. Ocean capacity is the one thing that’s actually loose, so use it while carriers are discounting to fill slots through February.

2. Rewrite your contract clauses. Force majeure language written for a typhoon doesn’t cover “the policy reversed and everyone got sick.” Get your lawyer to redraft with explicit reference to pandemic policy change, operating rate thresholds, and documented workforce absenteeism. Reference the 7 December State Council notice by name in the clause.

3. Dual-source anything on a single Chinese line. For every SKU where you’ve got one supplier in Jiangsu or Shandong, open a conversation with a secondary in Guangdong or an alternative origin entirely. LyondellBasell and Formosa in Taiwan, Huntsman in Singapore, Dow in Thailand, Sadara in Saudi Arabia. None are cheap, but none are on fire either.

4. Pre-book CBP/ABF documentation buffer. Build an extra five to seven days into your customs clearance assumption for Q1 2023. Chinese CIQ inspection and certificate issuance are going to lag, which means your CoA, MSDS, and shipping documents will arrive closer to vessel arrival than you’d like. Talk to your broker now.

5. Model an inventory uplift. If you normally hold 45 days, move to 75. If you hold 75, move to 110. The cost of carrying extra stock at current finance rates is material but it is less than the cost of being unable to supply your own customers in March.

6. Lock a forward freight rate for Q2. Ocean rates are at their lowest point in two years. Carriers (Hapag-Lloyd, Maersk, CMA CGM, MSC) are actively quoting 6 and 12 month contracts into mid-2023 well below spot. If you believe, as we do, that rates will bounce once Chinese production recovers and bookings surge in April-May, now is the window to fix.

The December 7 reversal solves nothing in the next 90 days. It creates the conditions for a recovery that starts in late February and takes until June to fully land. Plan for the February trough, fund the inventory buffer through Q1, and negotiate your supplier relationships as if your force majeure clause is about to be tested. Because it is.